Quantitative Bioanalysis that Speeds Up Therapeutic Innovation
Small molecule therapeutics demand accurate quantitative bioanalysis at every stage of the drug pipeline. From lead discovery to market authorization, confident decisions need reliable bioanalytical results.
Because of the potency of modern drugs, high sensitivity is crucial. The complexity of biological matrices might also compromise the accuracy of quantification. These are increasing challenges that bioanalysts must address.
Combining proprietary technology and methods with renowned support and service, SCIEX helps scientists to develop highly sensitive and accurate bioanalytical assays.
Without compromising on selectivity, accuracy, throughput, or cost, bioanalysts can confidently make decisions that will help to develop better therapeutics, faster.